PSA
48
-2
HIG
51
3
BWA
49
-6
FOX
68
-2
AAPL
64
11
UNP
43
3
PBI
59
-7
AKAM
59
-2
SBUX
32
-9
JNJ
36
3
EMR
64
-3
TROW
50
2
EW
53
-2
AIZ
66
-2
STZ
54
2
EMC
71
3
SCHW
53
-11
EL
34
-3
MAT
39
-6
MUR
34
-10
PSA
48
-2
HIG
51
3
BWA
49
-6
FOX
68
-2
AAPL
64
11
UNP
43
3
PBI
59
-7
AKAM
59
-2
SBUX
32
-9
JNJ
36
3
EMR
64
-3
TROW
50
2
EW
53
-2
AIZ
66
-2
STZ
54
2
EMC
71
3
SCHW
53
-11
EL
34
-3
MAT
39
-6
MUR
34
-10
Financhill
Back

Clinuvel Pharmaceuticals 10K Form

Sell
20

CLVLY
Clinuvel Pharmaceuticals

Last Price:
7.91
Seasonality Move:
0.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLVLY News And Ratings

See the #1 stock for the next 7 days that we like better than CLVLY

CLVLY Financial Statistics

Sales & Book Value

Annual Sales: $57.81M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $2.71
Price / Book: 2.92

Profitability

EPS (TTM): 0.45840
Net Income (TTM): $23.4M
Gross Margin: $51.2M
Return on Equity: 19.16%
Return on Assets: 16.45%

Clinuvel Pharmaceuticals Earnings Forecast

Key Clinuvel Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 20 years for CLVLY is 88.57%.
  • The Selling, General & Administrative Expenses for CLVLY have been equal to 28.38% of Gross Profit Margin.
  • The Research & Development expenses have been 259.75% of Revenue.
  • The Interest Expense is 12.50% of Operating Income.
  • The Net Earning history of CLVLY is 40.41% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 14 years.

Clinuvel Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLVLY
Website: clinuvel.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.81
Quick Ratio: 8.33

Price-to-Earnings

Trailing P/E Ratio: 17.28
Forward P/E Ratio: 0

CLVLY Technical Analysis vs Fundamental Analysis

Sell
20
Clinuvel Pharmaceuticals (CLVLY) is a Sell

Is Clinuvel Pharmaceuticals a Buy or a Sell?